Thursday, April 26th
16:00 PM – CET / 10:00 AM EDT
In this complimentary webinar, PharmaLex experts will provide updates for our UK and International audiences answering queries on how, as a Marketing Authorisation Holder (MAH), you can prepare for Brexit.
Following the outcome of the UK’s referendum on membership of the European Union, we have analysed the most feasible Brexit scenarios and what their impacts could be for the Pharmaceutical industry.
Key Learnings following this webinar
- How Brexit is likely to affect the obligations that come with being a MAH
- Why companies should be preparing systematically
- How a partner like PharmaLex can provide a rational and impartial perspective to achieve confidence in Brexit-readiness
We invite you to take part in the Q&A session at the end of the webinar and discuss any open questions with our speakers.
Matthew Walker, Senior Manager, Regulatory Affairs, PharmaLex UK
Victor Cowper, Manager, Client Services PharmaLex Ireland
You may address your questions at: firstname.lastname@example.org